13,616 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Acquired by Integrated Quantitative Investments LLC

Integrated Quantitative Investments LLC bought a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 13,616 shares of the medical instruments supplier's stock, valued at approximately $1,317,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. NewSquare Capital LLC purchased a new stake in shares of Merit Medical Systems during the 4th quarter valued at $32,000. Kohmann Bosshard Financial Services LLC bought a new stake in Merit Medical Systems in the fourth quarter worth about $52,000. Smartleaf Asset Management LLC boosted its stake in Merit Medical Systems by 237.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,388 shares of the medical instruments supplier's stock valued at $134,000 after acquiring an additional 977 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Merit Medical Systems by 14.7% during the 4th quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier's stock valued at $144,000 after acquiring an additional 191 shares during the period. Finally, TD Private Client Wealth LLC increased its stake in shares of Merit Medical Systems by 13.9% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier's stock worth $171,000 after purchasing an additional 211 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Price Performance

NASDAQ:MMSI traded up $0.05 during trading hours on Wednesday, hitting $88.53. The stock had a trading volume of 670,003 shares, compared to its average volume of 471,079. The company has a 50 day simple moving average of $103.11 and a two-hundred day simple moving average of $101.02. The firm has a market capitalization of $5.23 billion, a price-to-earnings ratio of 43.21, a P/E/G ratio of 2.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. Merit Medical Systems, Inc. has a one year low of $70.70 and a one year high of $111.45.

Remove Ads

Analyst Ratings Changes

Several equities analysts have weighed in on MMSI shares. Canaccord Genuity Group reduced their price objective on Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating for the company in a report on Wednesday, February 26th. Raymond James increased their price target on Merit Medical Systems from $105.00 to $110.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 31st. JPMorgan Chase & Co. assumed coverage on Merit Medical Systems in a research note on Friday, March 28th. They issued an "overweight" rating and a $120.00 price objective on the stock. Needham & Company LLC reiterated a "buy" rating and set a $116.00 target price on shares of Merit Medical Systems in a research report on Wednesday. Finally, Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a research note on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $111.70.

Insider Activity at Merit Medical Systems

In other Merit Medical Systems news, CFO Raul Jr. Parra sold 12,451 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $98.81, for a total transaction of $1,230,283.31. Following the sale, the chief financial officer now owns 24,201 shares in the company, valued at $2,391,300.81. This trade represents a 33.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Fred P. Lampropoulos sold 31,320 shares of Merit Medical Systems stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $103.86, for a total value of $3,252,895.20. Following the sale, the chief executive officer now directly owns 1,086,028 shares of the company's stock, valued at approximately $112,794,868.08. This trade represents a 2.80 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 109,132 shares of company stock valued at $11,139,521. Company insiders own 3.70% of the company's stock.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.